Literature DB >> 29410349

Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.

Mora Murri1, María Insenser1, Elena Fernández-Durán1, José L San-Millán1, Manuel Luque-Ramírez1, Héctor F Escobar-Morreale2.   

Abstract

PURPOSE: Circulating micro-ribonucleic acids (miRNAs) are small noncoding RNA molecules that influence gene transcription. We conducted the present profiling study to characterize the expression of circulating miRNAs in lean and obese patients with polycystic ovary syndrome (PCOS), the most common endocrine and metabolic disorder in premenopausal women. BASIC PROCEDURES: We selected 11 control women, 12 patients with PCOS and 12 men so that they were similar in terms of body mass index. Five control women, 6 men and 6 patients with PCOS had normal weight whereas 6 subjects per group were obese. We used miRCURY LNA™ Universal RT microRNA PCR for miRNA profiling. MAIN
FINDINGS: The expression of 38 miRNAs and was different between subjects with PCOS and male and female controls. The differences in 15 miRNAs followed a pattern suggestive of androgenization characterized by expression levels that were similar in patients with PCOS and men but were different compared with those of control women. The expression of 13 miRNAs in women with PCOS was similar to that of control women and different compared with the expression observed in men, suggesting sexual dimorphism and, lastly, we observed 5 miRNAs that were expressed differently in women with PCOS compared with both men and control women, suggesting a specific abnormality in expression associated with the syndrome. Obesity interacted with the differences in several of these miRNAs, and the expression levels of many of them correlated with the hirsutism score, sex hormones and/or indexes of obesity, adiposity and metabolic dysfunction. PRINCIPAL
CONCLUSIONS: The present results suggest that several serum miRNAs are influenced by PCOS, sex hormones and obesity. Our findings may guide the targeted search of miRNAs as clinically relevant markers for PCOS and its association with obesity and metabolic dysfunction in future studies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgens; Estrogens; Obesity; Polycystic ovary syndrome; Sex; microRNA

Mesh:

Substances:

Year:  2018        PMID: 29410349     DOI: 10.1016/j.metabol.2018.01.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

Review 1.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

Review 2.  Emerging roles for noncoding RNAs in female sex steroids and reproductive disease.

Authors:  Runju Zhang; Victoria Wesevich; Zhaojuan Chen; Dan Zhang; Amanda N Kallen
Journal:  Mol Cell Endocrinol       Date:  2020-07-12       Impact factor: 4.102

3.  Omics, big data and machine learning as tools to propel understanding of biological mechanisms and to discover novel diagnostics and therapeutics.

Authors:  Nikolaos Perakakis; Alireza Yazdani; George E Karniadakis; Christos Mantzoros
Journal:  Metabolism       Date:  2018-08-08       Impact factor: 8.694

Review 4.  Insulin resistance and PCOS: chicken or egg?

Authors:  P Moghetti; F Tosi
Journal:  J Endocrinol Invest       Date:  2020-07-09       Impact factor: 4.256

5.  Associations of plasma miRNAs with waist circumference and insulin resistance among women with polycystic ovary syndrome - Pilot study.

Authors:  Pandora L Wander; Daniel A Enquobahrie; Theo K Bammler; James W MacDonald; Sengkeo Srinouanprachanh; Thanmai Kaleru; Dori Khakpour; Subbulaxmi Trikudanathan
Journal:  Mol Cell Endocrinol       Date:  2022-07-14       Impact factor: 4.369

6.  CIRCULATING MIR-132, MIR-146A, MIR-222, AND MIR-320 EXPRESSION IN DIFFERENTIAL DIAGNOSIS OF WOMEN WITH POLYCYSTIC OVARY SYNDROME.

Authors:  Z Soyman; S Durmus; S Ates; G Simsek; V Sozer; B P Kundaktepe; D Kurtulus; R Gelisgen; V Sal; H Uzun
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

7.  Eicosapentaenoic Acid Improves Polycystic Ovary Syndrome in Rats via Sterol Regulatory Element-Binding Protein 1 (SREBP-1)/Toll-Like Receptor 4 (TLR4) Pathway.

Authors:  Yanting Wang; Jinying He; Jing Yang
Journal:  Med Sci Monit       Date:  2018-04-08

8.  Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome.

Authors:  Anja E Sørensen; Pernille B Udesen; Grzegorz Maciag; Julian Geiger; Negar Saliani; Andrzej S Januszewski; Guozhi Jiang; Ronald C Ma; Anandwardhan A Hardikar; Marie Louise M Wissing; Anne Lis M Englund; Louise T Dalgaard
Journal:  Front Med (Lausanne)       Date:  2019-11-01

9.  Prevalence and characteristics of polycystic ovary syndrome in Brazilian women: protocol for a nation-wide case-control study.

Authors:  Poli Mara Spritzer; Lucas B Marchesan; Betânia R Santos; Felipe V Cureau; Karen Oppermann; Rosana Maria Dos Reis; Rui A Ferriani; Rita Weiss; Ricardo Meirelles; Ana Lucia Candido; Fernando M Reis
Journal:  BMJ Open       Date:  2019-10-22       Impact factor: 2.692

10.  Whole Transcriptome Analysis: Implication to Estrous Cycle Regulation.

Authors:  Xiaopeng An; Yue Zhang; Fu Li; Zhanhang Wang; Shaohua Yang; Binyun Cao
Journal:  Biology (Basel)       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.